Scolaris Content Display Scolaris Content Display

Desinflación del balón de banda gástrica en el embarazo para la mejora de los resultados

Contraer todo Desplegar todo

Resumen

disponible en

Antecedentes

De acuerdo con el aumento en la prevalencia de la obesidad, un número cada vez mayor de mujeres en edad fértil están siendo sometidas a la colocación laparoscópica de bandas gástricas ajustables (CLBGA), lo cual resulta en un número cada vez mayor de embarazos en mujeres con una banda implantada. Actualmente, no hay consenso en cuanto al tratamiento óptimo de las bandas en el embarazo. Algunos médicos recomiendan dejar el balón de la banda insuflado para reducir el aumento de peso durante el embarazo y los resultados perinatales adversos asociados. Sin embargo, existe la inquietud de que el mantenimiento del balón insuflado durante el embarazo pudiese aumentar el riesgo de complicaciones de la banda y perjudicar el desarrollo o el crecimiento fetal como resultado de la ingesta nutricional reducida.

Objetivos

Comparar los resultados maternos y perinatales en cuanto a la desinflación de balón de banda gástrica electiva versus intención de mantener la insuflación del balón durante el embarazo.

Métodos de búsqueda

Se realizaron búsquedas en el registro de ensayos del Grupo Cochrane de Embarazo y Parto (Cochrane Pregnancy and Childbirth Group) (30 de septiembre de 2012) y en la base de datos Web o Science (desde 1940 hasta septiembre de 2012).

Criterios de selección

Ensayos controlados aleatorios que compararan la desinflación electiva del balón de banda gástrica con la intención de mantener la insuflación del balón en pacientes embarazadas sometidas a la CLBGA.

Obtención y análisis de los datos

Dos autores de la revisión evaluaron de forma independiente los estudios para su inclusión.

Resultados principales

Ningún estudio cumplió los criterios de para la inclusión en la revisión.

Conclusiones de los autores

Hasta la fecha no existen ensayos controlados aleatorios que comparen la desinflación electiva del balón de banda gástrica en el embarazo versus intención de mantener la insuflación del balón. Se necesita investigación adicional para definir el tratamiento óptimo del balón de banda gástrica en el embarazo.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Resumen en términos sencillos

disponible en

Desinflación del balón de banda gástrica en el embarazo para la mejora de los resultados

La obesidad y el aumento de peso excesivo durante el embarazo se asocian con resultados deficientes para la madre y el recién nacido. Los mismos incluyen diabetes gestacional, presión arterial elevada (hipertensión) en el embarazo, coágulos de sangre venosa (tromboembolia) en la madre, parto por cesárea, alto peso al nacer, mortinato, infección materna (septicemia), hemorragia materna profusa después del parto y muerte materna. Debido a que el número de mujeres en edad fértil que presentan obesidad ha aumentado tanto, también ha ascendido el número de mujeres en edad fértil sometidas a la cirugía bariátrica (pérdida de peso). Este hecho ha dado lugar a un mayor número de embarazadas con antecedentes de cirugía para la pérdida de peso. El procedimiento bariátrico más común es la colocación de bandas gástricas (colocación laparoscópica de bandas gástricas ajustables) en el cual se ubica una banda que contiene un balón lleno de líquido alrededor de la parte superior del estómago lo cual crea una bolsa superior pequeña que limita el transporte de los alimentos a la bolsa inferior. Este procedimiento reduce la capacidad de la persona de ingerir alimentos y de esa manera reduce la ingesta nutricional. El volumen del balón puede ajustarse mediante el agregado o la eliminación de líquido del balón.

Actualmente no hay guías sobre el mejor tratamiento de las bandas gástricas durante el embarazo y existe variación en cuanto a la atención. Algunos médicos recomiendan dejar el balón lleno (insuflado) para limitar el consumo de alimentos y limitar el aumento de peso durante el embarazo. Esta estrategia puede reducir la probabilidad de hipertensión materna o de diabetes gestacional y así mejorar los resultados para la madre y el recién nacido. Sin embargo, existe la inquietud de que el mantenimiento del balón insuflado podría reducir la ingesta de los nutrientes esenciales necesarios para el desarrollo y el crecimiento fetal normal. Además, es posible que ocurran complicaciones relacionadas con la banda con mayor frecuencia si el balón se mantiene insuflado, incluidas las náuseas y los vómitos, el deterioro o la migración de la banda debido a la mayor presión intraabdominal con el embarazo. Como resultado, algunos médicos prefieren eliminar el líquido para desinflar el balón cuando la paciente queda embarazada.

Esta revisión procuró comparar los resultados para las madres y los recién nacidos en función de si el balón se desinfla al comienzo del embarazo en comparación con el mantenimiento de la insuflación del balón en el embarazo. Ningún estudio cumplió los criterios de para la inclusión en la revisión. No es posible establecer conclusiones a partir de los ensayos controlados aleatorios con respecto al mejor tratamiento de la banda gástrica en el embarazo. Se necesita investigación adicional para definir el tratamiento óptimo del balón de banda gástrica durante el embarazo.

Authors' conclusions

Implications for practice

At present, there is no evidence to favour either elective deflation or maintaining gastric band balloon inflation in pregnancy. This lack of evidence is reflected in the wide variation in management of the gastric band in pregnancy which is seen in observational studies (Carelli 2011; Dixon 2001; Dixon 2005; Lapolla 2010; Sheiner 2009). Management decisions regarding band status in pregnancy should continue to be made according to the clinical context. Maternal weight at the beginning of pregnancy, nausea and vomiting, tolerability of the band, gestational weight gain, fetal growth, maternal wishes, and pregnancy complications should probably all be taken into account, but this review has not produced evidence to guide practice. Issues surrounding management of the gastric band should be discussed with women who should be involved in management decisions. Close surveillance of both mother and fetus should continue throughout pregnancy to identify any complications at an early stage (Guelinckx 2009). Effective care requires communication between all members of the multidisciplinary team including obstetricians, bariatric surgeons, bariatric physicians, dieticians and midwives.

Implications for research

As the prevalence of obesity is predicted to rise, so too the incidence of pregnancies following laparoscopic adjustable gastric banding is likely to increase. As the optimal management of women with a gastric band in pregnancy is unknown, there is a need for further research in this area to guide clinicians and pregnant women. This review supports the need for a randomised controlled trial in the area. A systematic review of observational studies could improve our understanding of gastric band management and help to design a randomised controlled trial. A randomised controlled trial would need to have three comparison arms to reflect current practice; elective deflation of the band balloon at the beginning of pregnancy, intention to leave the balloon inflated for the duration of pregnancy, and deflation of the balloon at the beginning of pregnancy with re inflation during the second trimester. Outcome measures should mirror those we intended to assess in this review, as they are both clinically important and meaningful to clinicians and patients (outcomes were selected as important for this review by a Maternity Service User Panel). Such a randomised controlled trial would need to be sufficiently powered to detect differences in primary maternal and perinatal outcomes for different forms of band management. Any bias should be minimised by adequate randomisation using random sequence generation, concealment of allocation to participants, study personnel and outcome assessors.

Background

As the prevalence of obesity increases, so too has the use of bariatric (weight‐loss) surgery, including laparoscopic adjustable gastric banding (LAGB). With women of reproductive age accounting for 49% of all those undergoing surgery (Maggard 2008), increasing numbers of women who have undergone this procedure are becoming pregnant. There are concerns about tolerability in pregnancy and the effect on maternal nutrition and body weight (Guelinckx 2009).

Description of the condition

Obesity is associated with poor health. Maternal obesity (defined as a body mass index (BMI) of equal to or greater than 30 in pregnancy), especially extreme obesity (BMI of equal to or greater than 50), is associated with higher rates of adverse pregnancy outcomes including gestational diabetes (odds ratio (OR) for extremely obese 15.7, 95% confidence interval (CI) 4.75 to 51.8) (CMACE 2010; CMACE 2011; Knight 2010), hypertensive disorders (OR 7.35, 95% CI 3.07 to 17.6 for nulliparous women with extreme obesity) (CMACE 2010; CMACE 2011; Knight 2010), reduced mobility and thromboembolism (CMACE 2010; CMACE 2011), delivery by caesarean section (OR 3.50, 95% CI 2.72 to 4.51) (CMACE 2010; Knight 2010; Usha Kiran 2005), postpartum haemorrhage (OR 1.5, 95% CI 1.2 to 1.8) (CMACE 2010; CMACE 2011; Usha Kiran 2005), fetal macrosomia (birthweight greater than 4.5 kg) (OR 5.23, 95% CI 2.81 to 9.74) (Knight 2010; Usha Kiran 2005), congenital malformations (including neural tube defects (OR 1.87, 95% CI 1.62 to 2.15), cardiovascular abnormalities (OR 1.30, 95% CI 1.12 to 1.51), and orofacial clefts (OR 1.20, 95% CI 1.03 to 1.40) (Stothard 2009), stillbirth (Salihu 2011) and maternal mortality (CMACE 2011). It has been reported that limiting gestational weight gain to less than 15 lb (approximately 7 kg) might reduce the incidence of adverse outcomes (Guelinckx 2009; Jensen 2005; Kiel 2007), but the evidence supporting this is not conclusive (Dodd 2010), and any limitation of gestational weight gain has to be balanced against the potential harms.

Description of the intervention

LAGB is a well‐established treatment for extreme obesity (Colquitt 2009) with proven safety and efficacy in achieving significant weight loss and improved health (Chapman 2004). The procedure involves laparoscopic placement of an adjustable band containing a fluid‐filled balloon around the upper portion of the stomach. This band acts to reduce stomach capacity, by creating a small upper stomach pouch and limiting passage of food into the lower digestive portion of the stomach, resulting in early satiation; aiding weight loss by reducing food intake. The volume of the balloon can be adjusted by addition or removal of fluid through a subdermal port positioned at the time of surgery. In this way nutritional intake, and thus body weight, can be influenced. Potential maternal and perinatal benefits of limiting weight gain in pregnancy have to be set against theoretical risks of leaving the balloon inflated. The reduction in nutritional intake from an inflated gastric band balloon might have adverse consequences. In general, reduced nutritional intake and low maternal weight gain are known to be associated with lower birthweight (OR 1.66, 95% CI 1.44 to 1.92) (Guelinckx 2009; Stotland 2006; Strauss 1999), and preterm labour (although this was a more significant finding in underweight ((OR 6.7, 95% CI 1.1 to 40.6) and normal‐weight (OR 3.6, 95% CI 1.6 to 8.0) women than overweight women (OR 1.6, 95% CI 0.7 to 3.5)) (Schieve 2000). Similarly, a systematic review did not find limiting gestational weight gain to be associated with small‐for‐gestational age in obese and overweight women (Siega‐Riz 2009). Recognised complications of LAGB also include gastric perforation, gastric necrosis, gastric prolapse, band leakage, and band migration and slippage (Chevallier 2004; Forsell 1999). The incidence of band migration and slippage of the band is increased in pregnancy because of raised intra‐abdominal pressure (Guelinckx 2009). Band migration often presents with nausea and vomiting and as these are common in normal early pregnancy, so band migration might go unrecognised initially, resulting in avoidable significant maternal morbidity. For these reasons, many advocate routine deflation of the band balloon at the beginning of pregnancy, but this might later result in excessive maternal weight gain and its associated complications, such as pregnancy complications (hypertensive disorders, gestational diabetes) (OR 2.10, 95% CI 1.74 to 2.54), caesarean delivery (OR 1.29, 95% CI 1.09 to 1.54) and increased birthweight (weight difference 206.45 g, 95% CI 178.82 to 234.08) (Mamun 2011).

Because of the controversy over appropriate gestational weight gain and concerns over band complications, management of gastric bands in pregnancy is inconsistent. Some clinicians advocate deflation of the gastric band balloon for the entire pregnancy allowing sufficient intake of nutrients to allow for fetal growth and development and potentially reducing the risk of band complications. This might, however, result in excessive gestational weight gain (defined by Institute of Medicine 2009 as 20 lbs or 9 kg for obese women) and its associated complications (Mamun 2011). Others promote a policy of leaving the balloon inflated for the duration of pregnancy with deflation only if significant complications such as band migration or severe nausea and vomiting occur (Lapolla 2010; Sheiner 2009). Another approach that has been employed is to deflate the balloon in the early part of pregnancy with re‐inflation at the beginning of the second or third trimesters (Dixon 2001), or selective adjustment of the balloon according to tolerance and gestational weight gain (Carelli 2011; Dixon 2005; Martin 2000; Skull 2004; Weiss 2001). These approaches might reduce the risk of aggravating symptoms of nausea and vomiting in early pregnancy and allow sufficient intake of crucial micronutrients during organogenesis, and yet still limit excessive gestational weight gain and its associated complications in later pregnancy.

How the intervention might work

Leaving the balloon deflated throughout pregnancy would allow sufficient intake of nutrients for maternal and fetal health while potentially reducing the rate of nausea and vomiting and more serious complications such as band slippage and nutritional deficiencies.

Maintaining inflation of the balloon for the duration of pregnancy might limit gestational weight gain (Carelli 2011), and so reduce adverse maternal and perinatal outcomes (CMACE 2010).

Why it is important to do this review

With the growing prevalence of obesity, the incidence of pregnant women who have undergone LAGB procedures is increasing (Maggard 2008). Currently, no guidance exists for maternity healthcare workers on how best to manage gastric bands to achieve optimum maternal and neonatal outcomes (Maggard 2008).

Objectives

To compare maternal and perinatal outcomes for elective gastric band balloon deflation versus intention to leave the balloon inflated during pregnancy.

Methods

Criteria for considering studies for this review

Types of studies

According to the study protocol (Jefferys 2012), only randomised, quasi‐randomised, and cluster‐randomised controlled trials were eligible for inclusion in the review. Multi‐arm studies were also considered. We intended to include studies presented only as abstracts and to explore their impact in a sensitivity analysis. Abstracts were assessed in the same way as full papers. We planned to include abstracts in the main meta‐analysis if there was sufficient information presented in the abstract to demonstrate that it met the review's inclusion criteria and was of an acceptable methodological standard. We planned to exclude studies (with a note in the excluded studies table explaining that these studies would be reconsidered for inclusion once the full publication becomes available, or once the authors have provided more information) if there were doubts about the eligibility of the study or if it was thought to be at risk of serious bias, for example, in terms of randomisation methods, withdrawals or post‐randomisation exclusions.

Types of participants

Pregnant women who have previously undergone adjustable gastric banding, with the band still inflated.

Types of interventions

Studies comparing elective deflation of the gastric band balloon in different trimesters of pregnancy or throughout versus intention to leave the balloon inflated for the duration of pregnancy.

Types of outcome measures

The outcome measures included in our review have been short‐listed on the basis of being meaningful to clinicians, public, and policy makers, and have been discussed and agreed with a Maternity Service User Panel of six lay women.

Primary outcomes
Maternal

  • Gestational diabetes (as defined by individual trial)

  • Hypertensive disorders of pregnancy (pregnancy‐induced hypertension and/or pre‐eclampsia)

  • Postpartum haemorrhage (as defined by individual trial)

  • Tolerance to intervention (nausea/vomiting)

Neonatal

  • Admissions to neonatal unit

We intended to include primary outcomes in the 'Summary of findings' table.

Secondary outcomes
Maternal

  • Maternal weight gain during pregnancy (average (5 kg to 9 kg), % excessively high (greater than 9 kg), % excessively low (below 5 kg)) as defined by Institute of Medicine 2009)

  • Mode of birth (normal birth, operative vaginal birth, caesarean birth)

  • Maternal admission to hospital for any reason in the antenatal and postnatal period (up to six completed weeks)

  • Venous thromboembolism in the antenatal and postnatal period (up to six completed weeks)

  • Anaemia in pregnancy (haemoglobin (Hb) less than 11% (WHO 2001); or as defined by individual trial)

  • Actual balloon status in each trimester (remained inflated, or was deflated for maternal preference or clinical reasons, or re inflated) (if stated)

Fetal/neonatal

  • Two‐year survival‐free disability

  • Low Apgar score (less than seven at five minutes)

  • Preterm birth (less than 37 completed weeks): a. spontaneous b. iatrogenic c. total

  • Extremely preterm birth (less than 28 completed weeks)

  • Birthweight

  • Large‐for‐gestational age (birthweight greater than 90th centile; or as defined by individual trial)

  • Macrosomia (greater than 4000 g; or as defined by individual trial)

  • Small‐for‐gestational age (birthweight smaller than 10th centile; or as defined by individual trial)

  • Stillbirth

  • Early neonatal death (first seven days)

  • Perinatal mortality (stillbirth and early neonatal death (WHO))

  • Congenital malformations (orofacial clefts, cardiac septal defects, neural tube defects)

Search methods for identification of studies

Electronic searches

An electronic search was performed as per the review protocol (Jefferys 2012).

We contacted the Trials Search Co‐ordinator to search the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2012). 

The Cochrane Pregnancy and Childbirth Group's Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from:

  1. monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);

  2. weekly searches of MEDLINE;

  3. weekly searches of EMBASE;

  4. handsearches of 30 journals and the proceedings of major conferences; and

  5. weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.

Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the 'Specialized Register' section within the editorial information about the Cochrane Pregnancy and Childbirth Group.

Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. 

In addition, we searched the Web of Science database (1940 to September 2012) using the search strategy detailed in Appendix 1.

Searching other resources

We planned to search reference lists of retrieved studies.

We did not apply any language restrictions.

Data collection and analysis

Selection of studies

Two review authors (A Jefferys (AJ) and D Siassakos (DS)) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. Any disagreements were resolved through discussion and, if required, we planned to consult a third assessor (R Fox (RF)).

There are no included studies. Methods of data extraction and management (as detailed in our protocol (Jefferys 2012)) will be used in future updates of this review, as more data become available, see Appendix 2.

Results

Description of studies

Results of the search

The results of the search are summarised in the study flow diagram Figure 1. The search of the Cochrane Pregnancy and Childbirth Group's Trials Register retrieved no studies. The Web of Science generated six citations. All of these were excluded on review of the abstracts ‐ the decision was unanimous.


Study flow diagram.

Study flow diagram.

Included studies

No studies met the criteria for inclusion in the review.

Excluded studies

Six studies were excluded at the stage that the abstracts were reviewed (one letter, three retrospective analysis of revision rates following pregnancy, one assessing outcomes in adolescents following banding (excluded as the participants were not pregnant), one analysis of nutrient deficiency post gastric bypass (excluded as participants were not pregnant and they had undergone gastric bypass rather than gastric banding)).

Risk of bias in included studies

No studies met the criteria for inclusion in the review, therefore, no assessment of bias was required.

Effects of interventions

No studies met the criteria for inclusion in the review, therefore, no conclusion can be drawn as to the effect of balloon deflation or maintaining inflation of the balloon.

Discussion

Summary of main results

Our search found no randomised controlled trials to date comparing elective deflation of laparoscopic adjustable gastric banding in pregnancy versus intention to maintain balloon inflation. It is therefore unknown whether it is better to routinely deflate a gastric band balloon in pregnancy or to maintain balloon inflation with respect to maternal and neonatal outcomes.

Overall completeness and applicability of evidence

A full search for randomised controlled trials was performed. Although case series and case‐control studies addressing band management in pregnancy exist, these are not eligible for inclusion in this review.

Agreements and disagreements with other studies or reviews

There are no other reviews addressing this issue.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.